Skip to content

What’s New

  • New Maudsley deprescribing guidelines available: This can be viewed as a significant update to the Ashton Manual, which introduces non-linear tapering and embraces the concept of a patient-led taper. See the Resources page for details.
  • A new research paper featuring an international scoping review on prescribing and deprescribing guidance for benzodiazepines and Z-drugs has been published. This multi-year project was led and contributed to by several Alliance scientists. Click here to read the article.
  • The Alliance 2023 annual report highlights our work and accomplishments over the past year, click here to see what we’ve been up to.
  • New Paper Out Now: ‘We need more support and doctors that understand the process of tapering …’ The aim of this study was to conduct a content analysis of the views and experiences of discontinuing long-term BZRA use. Click here read the paper

Coming Soon

  • Deprescription Guidelines from ASAM and FDA will be out for public comment in June, stay tuned for updates and how to share your opinion.
  • New deprescription phone apps are being researched and developed by 2 research groups to help patients with their tapering process, stay tuned for updates.


The Alliance is launching a new campaign across our social media channels to help share real stories from people who have been affected by benzodiazepines. Click here to learn more.

Our Programs

The Alliance has many programs that will help prescribers make evidence-based decisions and will help patients get the help they need.  We are composed of professionals dedicated to solving the benzodiazepine crisis.

Patient’s Guide to the Site

If you are currently prescribed or have previously taken benzodiazepines, you may be experiencing the pain and confusion of dependence or withdrawal. These steps will help you navigate our site and the resources for recovery.

Information for Prescribers

Although helpful for short-term use, benzodiazepines and Z-drugs do not provide safe and effective options over the long term for such conditions as anxiety and insomnia, where they are commonly and inappropriately used. There is evidence to support alternative methods for treatment and prescription practices.

Resources

Directly access guidelines, drug labels and more. Our unique BZD and Z-drug library is sorted by categories, and feature tables of contents for easy access to over 1000 papers.


Each year, thousands of adults and teens are harmed by benzodiazepine due to over-prescribing.
We help individuals get the help they need, and we help prescribers offer better practices.

testimonials

Facts About Benzodiazepines

1 person in 8

BZD Prescription Rate

57%

Chance of suffering BIND
after 4 weeks’ use

Globe

>300K

MedWatch BZRA
Problem Reports

>65K

Deaths involving BZDs
(MedWatch)

Facts About the Alliance

11

Scientific papers published

8

Scientific papers being written

59

CME Courses Delivered

11,000

Prescribers educated

>200K

Projected future BZD dependencies avoided

Follow the Latest Benzodiazepine and Z-drug Developments

  • Proposed Benzodiazepine Tapering Guideline
    What is it? Since 2022, the American Society of Addiction Medicine (ASAM) has been working on producing a set of recommendations to guide practitioners in the often-difficult task of helping benzodiazepine-dependent patients discontinue this medication.  The ASAM Clinical Practice Guideline on Benzodiazepine Tapering has gone through several iterations and reviews.  Even before being written, this… Read More »Proposed Benzodiazepine Tapering Guideline
  • ASAM Guidelines Public Comment
    Now is your chance to make your voice heard! The American Society of Addiction Medicine (ASAM) has opened the period for public comment on the first national benzo deprescription (tapering) guidelines. These guidelines will be how clinicians will treat their benzo patients for at least the next 10 years. It is very important that these… Read More »ASAM Guidelines Public Comment
  • Jobs
    Director of Development and Business (Posted 2/26/24) The Alliance for Benzodiazepine Best Practices is seeking to add our first Director ofDevelopment and Business to our team. The Director is responsible for planning,organizing, and directing the Alliance’s fundraising and business activities inaccordance with our strategic plan. Click here to view the entire job posting. To apply,… Read More »Jobs